Ontario becomes the first province to list fluvoxamine as a COVID-19 treatment to consider
Ontario has become the first province to list an inexpensive and well-known antidepressant as a treatment doctors can “consider” for patients with a mild COVID-19 infection in a bid to keep them out of hospital.
In the science table listing on Wednesday, a panel indicated that the drug fluvoxamine can be considered and prescribed to patients with a mild case who are at risk of having more severe symptoms.
Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) antidepressant that is typically used to treat depression and obsessive-compulsive disorders.
“Right now, we're in a really unprecedented wave of Omicron and we have just a staggering number of patients getting infected,” Dr. Menaka Pai, associate professor of medicine at McMaster University and co-chair of the Ontario COVID-19 Science Advisory Table, told CTV News. “Our goal is to keep them safe, to keep them out of hospital and also to preserve our scarcest resource, which I would say is our hospital beds.”
The drug costs a little more than a dollar a day and would be taken for 15 days, starting with a small dose. In comparison, the antivirals medicines from Pfizer and Merck cost nearly $1,000 dollars per patient.
Studies have shown that the drug can cut hospital admissions due to COVID-19 by up to 30 per cent.
“When you look at all that data together, it is very likely that fluvoxamine prevents hospitalization in patients with mild COVID-19,” Pai said. “So patients who are not yet on oxygen, and if our goal in this wave of the pandemic is to stop patients with COVID from ending up in those scarce hospital beds, then that I think is a very important finding, indeed.”
Researchers at McMaster University monitored more than 1,500 unvaccinated COVID-19-positive patients for a month and gave them either the drug or a placebo.
Of those who received fluvoxamine, 10.6 per cent required treatment by a doctor for more than six hours or were hospitalized, while 15.7 per cent of the participants who received a placebo were hospitalized or needed physician treatment for more than six hours. When patients took all of their drugs, the noted beneficial effect went up to 65 per cent, the study found.
Dr. Edward Mills, the co-principal investigator of the trial, said the results could be a game-changer, particularly in developing countries with low vaccination rates.
“It’s a very large treatment effect, one that hasn’t been observed for any drug yet,” he told CTV News back in October when the study was published.
John’s Hopkins University has also endorsed the drug for use within seven days of symptoms, provided the patient is not in their third trimester of pregnancy.
While Ontario is the first province to list the drug as an option, Pai said other regions are also considering the medication as a possible preventative therapy.
COVID-19 COVERAGE
CTVNews.ca Top Stories
New alcohol recommendations could speed up changing drinking habits: businesses
Advocates and business owners in the beverage industry say new guidance for drinking alcohol could speed up changing consumer drinking habits as younger generations drink less and non-alcoholic beverages become more popular.

Adding milk to coffee may be anti-inflammatory: Danish study
Adding some milk to your morning coffee may boost the body's anti-inflammatory response, new research out of Denmark shows.
Girl, 6, dead after accident at ski resort north of Montreal on Sunday
A six-year-old girl died in hospital Sunday night after being involved in an incident at the Val-Saint-Côme ski resort in Lanaudiere. Quebec police are investigating, though details into the event are not yet known. Officers indicated that it involved a T-bar lift, but they were not able to say more.
WHO: COVID-19 still an emergency but nearing 'inflection' point
The coronavirus remains a global health emergency, the World Health Organization chief said Monday, after a key advisory panel found the pandemic may be nearing an 'inflection point' where higher levels of immunity can lower virus-related deaths.
Quebec minister calls on new anti-Islamophobia representative to step down over Bill 21 comments
Quebec's minister responsible for secularism, Jean-Francois Roberge, has called on Canada’s new special anti-Islamophobia advisor Amira Elghawaby to apologize and step down.
Health, economy, crime top issues of concern as House of Commons resumes
Members of Parliament return to Ottawa to resume sitting for the first time in 2023 on Monday, with the state of Canada's health-care system, the health of the Canadian economy, and rates of violent crime in this country all top of mind.
Hockey Hall of Famer Bobby Hull dies at 84
Hockey Hall of Famer Bobby Hull has died at the age of 84. He played for the NHL's Chicago Blackhawks and Hartford Whalers as well as the World Hockey Association's Winnipeg Jets over a 23-year pro career.
Are you a Ukrainian who recently moved to Canada? We want to hear from you
With Russia's invasion of Ukraine displacing millions of people, many refugees have begun to lay their roots in Canada. If you or someone you know has fled the war-torn country and settled in Canada, we want to hear from you.
NDP to call for emergency debate in House of Commons over private health care
Federal New Democrat Leader Jagmeet Singh says he will call on the House of Commons to hold an emergency debate on the privatization of health care.